Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)

Revenue by Segment

Financials in millions JPY. Fiscal year is March - February.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021	Feb 29, 2020	Feb 28, 2019	Feb 28, 2018	Feb 28, 2017
Pharmaceuticals Business	163.02B	-	138.46B	125.20B	117.29B
Others	-	3.35B	3.25B	3.13B	2.90B
Medicine and Related Product Business	-	152.65B	-	-	-
Total	163.02B	156.01B	141.71B	128.33B	120.19B

Revenue by Geography

Financials in millions JPY. Fiscal year is March - February.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021	Feb 29, 2020	Feb 28, 2019	Feb 28, 2018	Feb 28, 2017
Others	37.80B	34.75B	29.64B	25.40B	19.36B
United States of America	44.87B	38.90B	31.04B	28.30B	22.11B
Japan	80.35B	82.36B	81.03B	74.64B	78.73B
Total	163.02B	156.01B	141.71B	128.33B	120.19B

Data Source: S&P Global Market Intelligence Last updated: Feb 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 9, 2026

Data Sources Report a data error